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Highlights 
 Strain differences in acute cadmium immunotoxicity are explored in DA and AO rats 
 Cadmium  affected  spleen and lungs cells immune response in DA and AO rats 
 The degree of some changes differ between strains in both compartments 
 Data depict complex influence of genetic background on the cadmium immunotoxicity  
 Abstract  
The impact of genetic background on effects of acute i.p. cadmium administration (0.5 mg/kg and 1 mg/kg) on basic immune activity 
of spleen and lungs was examined in two rat strains, Albino Oxford (AO) and Dark Agouti (DA), known to react differently to 
chemicals. More pronounced inhibition of Concanavalin A (ConA)-induced and Interleukin (IL)-2 stimulated spleen cell proliferation 
as well as higher levels of nitric oxide (known to decrease cell`s proliferative ability) in DA rats at 1 mg/kg, along with greater 
inhibition of ConA-induced Interferon (IFN-γ)-production by total and mononuclear (MNC) spleen cells and IL-17 production by 
spleen MNC in DA vs. AO rats at this dose show greater susceptibility of this strain to Cd effects on spleen cells response. More 
pronounced infiltration of neutrophils/CD11b
+
 cells to lungs of DA rats treated with 1 mg/kg of Cd and decreased IL-17 lung cell 
responses noted solely in DA rats speaks in favor of their higher susceptibility to this metal. However, lack of strain disparity in lung 
cells IFN-γ responses show that there are regional differences as well. Novel data from this study depict complexity of the influence of 
genetic background on the effects of cadmium on host immune reactivity.  
Keywords: Cadmium; Rats; Albino Oxford (AO) and Dark Agouti (DA) strains; Spleen; Lungs   
 
1. Introduction 
Cadmium (Cd), an industrial pollutant and component of cigarette smoke, is one of the most toxic metals in the environment (Morselt, 
1991). It adversely affects a number of organs and tissues such as liver and kidneys (which are cadmium prime targets), as well as 
lungs, testes and brain (U.S. Department of Health and Human Services, 1997; WHO, 1992). Effects of cadmium on the components 
of immune system were less investigated and showed both suppression (Marth et al., 2001; Pathak and Khandelwal, 2007) and 
stimulation (Olszowski et al., 2012).  
The susceptibility  of tissues to cadmium toxicity is associated with several host physiological parameters including age and sex 
(Gochfeld, 1997). Differences in cadmium hepatotoxicity were observed between young and adult mice (Shaikh et al., 1993) and rats 
(Yamano et al., 1998) and in hepatotoxicity and nephrotoxicity between male and female rats (Gubrelay et al., 2004). Host genetic 
variability was considered as a factor that could identify the degree of susceptibility to metals in general (Gochfeld, 1997;), but the 
factors that render some animals more prone to toxicity than the others are not well known. Strain differences noted in hepatotoxicity 
and testicular toxicity of cadmium in rats were shown as related to the levels of its accumulation in  liver (Shaikh et al., 1993; Shimada 
et al., 2004)
 
and testes (Shimada et al., 2009, 2011). However, several studies showed that cadmium burden is less important than host 
genetic background, as strain differences in hepatotoxicity (Kuester et al., 2002; )
 
and testicular toxicity (King et al., 1998; Liu et al., 
2001;) were noted in the presence of similar tissue concentrations of this metal. Differential susceptibility of some tissues to cadmium 
has been ascribed to differences in the activity of these tissues cells . Kupffer cells (liver macrophages) were shown to be the major 
determinant of differential susceptibility of Fischer 344 and Sprague-Dawley rats (which accumulated similar levels of cadmium in  
liver) to hepatotoxicity of cadmium (Kuester et al., 2002). Differential intensity of leukocyte infiltration into  lungs accounted for 
strain differences in the susceptibility of C57BL/6 and DBA mice (which accumulated similar levels of metal) to cadmium-induced 
pulmonary injury (McKenna et al., 1997). These two studies showed not only the contribution of cells of immune system to strain 
differences in cadmium tissue toxicity in experimental rodents, but they also suggested the influence of genetic variations to cadmium 
toxicity to immune system. Indeed, one early study showed differential effects of cadmium administration on thymic lymphocytes of 
Brown-Norway and Lewis rats, although the same amount of this metal was observed in thymuses of both strains (Morselt et al., 
1988). Examination of  in vitro cadmium exposure on cytokine responses by human peripheral blood mononuclear cells showed high 
level of inter-individual variability of cytokine mRNA levels (coefficient of variation between distinct blood donors of up to 68%) 
(Marth et al., 2001). Despite these early data, the impact of genetic background on cadmium toxicity to cells of immune system is 
largely unknown.  
Differential effects of cadmium on components of immune system (suppression, stimulation or lack of the impact) were reported in 
the literature, most probably due to differences in sources of immune cells (blood, spleen, thymus, lungs)  used in the studies.  
Differential effects of cadmium in the same tissue (spleen) might be ascribed to differences in the activities examined(Demenesku et 
al., 2014) In  view of the above cited findings the aim of the present paper was to examine the impact of genetic background on 
immunomodulatory potential of cadmium by analyzing its effects on  spleen and lung immune responses comparatively in  Albino 
Oxford (AO)    and Dark Agouti (DA) rats (strains which are known to differ in immune-mediated tissue responses). To this aim, 
basic aspects of immune activity of spleen and lung leukocytes were analyzed in animals of these strains following acute 
intraperitoneal (i.p.) cadmium administration. The data  obtained  showed  complexity of the influence of genetic background on the 
effects of cadmium on host immune reactivity, which is a novel finding.  
 
2. Materials and methods  
2.1 Chemicals 
Cadmium chloride (CdCl2) was purchased from Serva, Feinbiochemica (Heidelberg, Germany) and was prepared in sterile pyrogen-
free saline (Hemofarm AD, Vršac, Serbia). Concanavalin A (ConA), deoxyribonuclease I (DNase I), o-dianisidine dihydrochloride, 
three-(4,5-dimethyl-thiazol-2-yl)-2,5 diphenyl-tetrazolium bromide (MTT), myeloperoxidase (MPO), N-(1-naphtyl) ethylenediamine 
dihydrochloride, sulfanilamide (p-aminobenzenesulfonamide) were all purchased from Sigma (Sigma Chemical Co., St. Louis, MO, 
USA). Collagenase (type IV) purchased from Worthington Biochemical Corporation (Lakewood, USA), hydrogen peroxide (H2O2) 
from Zorka Farma Sabac (Serbia) and sodium nitrite  from Fluka Chemika (Buchs, Switzerland) were used in experiments. Culture 
medium RPMI-1640 (Biowest, Nuaillé, France) supplemented with 2 mM glutamine, 20 μg/ml gentamycine (Galenika a.d., Zemun, 
Serbia), 5% (v/v) heat inactivated fetal calf serum (Biowest, Nuaillé, France) was used in cell culture experiments. For use in 
experiments ConA was dissolved in RPMI-1640 medium. All solutions for cell culture experiments were prepared under sterile 
conditions and sterile filtered (Minisart, pore size 0.20 μm, Sartorius Stedim Biotech, Goettingen, Germany) before use. 3H-thymidine 
(GE Healthcare, Little Chalfont, UK) was prepared in culture medium. Monoclonal antibody OX-42 (mouse anti-rat CD11b/CD11c) 
was purchased from AbD Serotec (Serotec Ltd., Oxford, UK). Lysis buffer (used for red blood cell lysis), phycoerythrin (PE) labeled 
F(ab‟)2 goat anti-mouse IgG and mouse anti-rat CD25 were from eBioscience (eBioscience Inc., San Diego, CA, USA). Recombinant 
human interleukin-2 (IL-2; E. coli-derived, Ala21-Thr153) was obtained from R&D Systems (Minneapolis, USA).  
 
2.2 Animals and cadmium treatment 
All animal procedures were complied with the Directive 2010/63/EU on the protection of animals used for experimental and other 
scientific purposes and was approved by the Ethical Committee of the Institute for Biological Research “Sinisa Stankovic” (IBISS), 
University of Belgrade, Serbia. Twelve to fourteen weeks-old male Dark Agouti (DA) and Albino Oxford (AO) rats, conventionally 
housed at IBISS, in controlled environment (21/24 °C temperature, a 60 % relative humidity and 12-hour (h) light:dark cycle) were 
used. All rats had ad libitum access to standard rodent chow and filtered water throughout the study.  
Four to six animals were assigned per group per experiment in two independent experiments. Sterile filtered CdCl2 was administered 
by i.p. injection at a concentration at which animals received 0.5 or 1 mg of cadmium/kg body weight (b.w.) in a 0.5 ml dosing 
volume. Control group was administered with pyrogen-free saline solely. All measurements were carried out 48 h post-cadmium 
exposure in animals anesthetized by i.p. injection of 40 mg/kg b.w. of thiopental sodium (Rotexmedica, Tritau, Germany). 
 
2.3. Cadmium determination 
Atomic absorption spectrometry graphite tube technique (AAS Varian 1275; graphite tube, GTA-95, Palo Alto, CA, USA) was used 
for cadmium content determination in liver, spleen, kidneys and lungs. Lyophilized tissue samples were homogenized and digested in 
a microwave digestion system (MBS-9, CEM Innovators, Buckingham, UK) in a mix of concentrated HCl and HNO3 (metal-free), 
filtered and diluted using metal-free ultrapure water. Reference materials were used as control samples: SeronormTM Trace Elements 
Serum L-1 and ClinChek Plasma Control. Method limit of detection (LOD) was 0.1 mg/kg (0.00089 mmol/kg) and limit of 
quantification (LOQ) 0.3 mg/kg (0.00267 mmol/kg). The concentrations were expressed as μmol of Cd per kg of wet tissue. 
 
2.4. Clinical biochemistry 
Heparinized plasma obtained from whole blood samples collected at necropsy, was assessed for levels of aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) activity using an autoanalyzer (Ciba Corning Express, Oberlin, OH) and commercially 
available reagents. Specific gravity, pH, white blood cell number, protein, nitrite, blood/hemoglobin, urobilinogen, bilirubin, glucose, 
and ketone content in urine was measured in samples freshly collected (by micturition over Petri dish) 48 h post-cadmium exposure 
using semi quantitative Multistix
® 
10SG urine strips (Bayer Diagnostics, Tarrytown, NY, USA). 
 
2.5. Peripheral blood leukocyte counts 
Total peripheral blood leukocyte cell counts were determined using an improved Neubauer hemocytometer (Neubauer, Wertheim, 
Germany). The differential cell counts were determined in air-dried whole-blood smears stained according to a standard May 
Grünwald-Giemsa/MGG (Alkaloid AD, Skopje, The Former Yugoslav Republic of Macedonia) protocol by differentiating at least 300 
cells.  
 
2.6. Histology 
Samples of livers, kidneys, spleens and lungs were cut out and immediately fixed in 4% formaldehyde (pH 6.9), processed for 
embedding in paraffin wax and subsequently sectioned at 5 μm. Hematoxylin and eosin (H&E)-stained histology slides were analyzed 
(in a blinded manner) by a certified histopathologist using a Coolscope digital light microscope (Nikon Co, Tokyo, Japan). 
 
2.7. Spleen cell isolation and culture 
Spleens were removed, blotted dry and weighed. The relative spleen weight was calculated according to the following formula: organ 
weight (in mg)/b.w. (in g). Spleen cell differential counts were determined by differentiating at least 1000 cells from air-dried spleen 
blood smears (prepared from a fresh section of spleen) stained according to MGG protocol. Spleen cells were obtained by mechanical 
disintegration of spleen tissue through a cell strainer (BD Falcon, BD Bioscience, Bedford, USA), and suspended in complete RPMI-
1640 culture medium. Cell viability was determined by Trypan blue dye exclusion and was more than 95%. 
For proliferation measurements, total spleen cells (3 × 10
5
 cells/well) were cultured in medium solely (spontaneous proliferation), 
medium supplemented with 2.5 μg/ml ConA (ConA-stimulated), or in medium with 0.25 μg/ml ConA and 20 ng/ml of IL-2 (IL-2-
stimulated proliferation). After 48 h of culture 0.5 μCi of  3H-thymidine per well was added and incubation was continued for 
additional 16 h. Incorporation of 
3
H-thymidine into cellular DNA was measured by liquid scintillation counting (LKB, Wallac, Turku, 
Finland) and proliferation was expressed as counts per minute (c.p.m.).  
For examination of nitric oxide (NO) production, spleen cells (3 × 10
5
 cells/well) were cultured in 96-well microplates (Sarstedt Inc., 
Newton, NC) for 48 h in medium supplemented with 2.5 μg/ml ConA. 
Mononuclear spleen cells were obtained by centrifugation (700 × g, 20 min, 20 °C) of spleen cell suspension over Percoll density 
separation medium (Sigma Chemical Co., St. Louis, MO, USA). 
Total and mononuclear spleen cells (3 × 10
5
 cells/well) were cultured for 48 h in medium solely (non-stimulated cytokine production) 
or in the presence of 1 μg/ml ConA (ConA-stimulated cytokine production). 
 
2.8. Lung leukocyte isolation and culture  
Lungs were removed, cleared of blood and weighed. The relative lungs‟ weight was calculated according to the following formula: 
organ weight (in mg)/b.w. (in g). Tissue (left lung) was homogenized on ice using an IKA T18 basic homogenizer (IKA Works INC., 
Wilmington NC) in sterile saline. Homogenates were then subjected to sonication (3 × 15 s on ice at 30% of maximum intensity 
amplitude) by a laboratory sonicator (Bandelin electronic, UW 2070, Berlin, Germany). 
Right lung was finely minced and incubated with gentle mixing (magnetic stirrer) for half an hour at 37 °C in culture medium 
supplemented with 1.0 mg/ml collagenase and 30 μg/ml DNase. Cells were resuspended in complete RPMI-1640 culture medium and 
counted by improved Neubauer hemocytometer. Cell viability was determined by Trypan blue dye exclusion and was always >90%. 
Differential cell counts were determined by examining at least 300 cells from lung cells cytospin preparations stained with MGG 
protocol.  
Mononuclear cells were obtained by centrifugation of lung cell suspension over Percoll density separation medium (700 × g, 20 min, 
20 °C).  
Total and mononuclear lung cells were resuspended in complete RPMI-1640 culture medium and cultured for 48 h in medium solely 
(non-stimulated cytokine production) or in the presence of 1 μg/ml ConA (ConA-stimulated cytokine production). 
 
2.9. MTT assay for cell viability  
A quantitative colorimetric assay described for lymphocyte cell lines (Denizot and Lang, 1986)
 
in which tetrazolim salt MTT is 
metabolically reduced by cell‟s mitochondrial dehydrogenases to colored end product formazan, was used as a measure of isolated 
leukocytes' metabolical viability. Spleen (3 × 10
5
 cells/well) or lung (4 × 10
5
 cells/well) cells were incubated with 500 μg/ml of MTT 
for 3 h in 96-well plate. Formazan produced by cells was dissolved by overnight incubation in 10% SDS-0.01N HCl. Absorbance was 
measured spectrophotometrically at 540/650 nm, by an ELISA 96-well plate reader (GRD, Rome, Italy). 
 
2.10. Myeloperoxidase (MPO) activity 
MPO activity was assessed on the basis of the oxidation of o-dianisidine dihydrochloride by cells (Bozeman et al., 1990). MPO was 
evaluated by addition of 33 μl of spleen or lung cell lysate (obtained by repeated freezing and thawing) or the lung tissue homogenate 
to 966 μl of substrate solution (0.167 mg/ml o-dianisidine dihydrochloride and 0.0005% H2O2 in 50 mM potassium phosphate buffer, 
pH 6.0). Absorbance was read at 450 nm by an ELISA 96-well plate reader during ten min at three-min intervals against the MPO 
standard. Values were expressed as MPO units (U)/10
6
 cells or MPO U/g of tissue. 
 
2.11. Nitric oxide (NO) production 
As an indicator of NO formation, the concentration of the stable NO oxidation product, nitrite, was measured using Griess assay 
(Hibbs et al., 1988) in medium conditioned for 48 h by total spleen cells. Aliquots (50 μl) of conditioned medium were mixed with an 
equal volume of Griess reagent (a mixture of 0.1% N-(1-naphtyl) ethylenediamine dihydrochloride in water and 1% sulfanilamide in 
5% phosphoric acid) and incubated for 10 min at room temperature. Following incubation, the absorbance was measured at 540 
nm/670 nm by an ELISA 96-well plate reader. The amount of present nitrite was obtained by extrapolation from a standard curve 
constructed in parallel with known concentration of sodium nitrite solutions. 
 
2.12. Flow Cytometry  
Adhesion molecule CD11b expression measurement was achieved by flow cytometry analysis of peripheral blood leukocytes 
following lysis of red blood cells. Obtained cells (1 × 10
6
) were incubated with mouse anti–rat CD11b on ice for 30 min, washed and 
stained with PE labeled F(ab‟)2 goat anti-mouse IgG for further 30 min. To determine numbers of CD25
+
 cells, 1 × 10
6
 spleen cells were 
incubated on ice for 30 min with PE labeled mouse anti-rat CD25 antibody. Following staining, cells were washed, fixed with 1 % 
paraformaldehyde and kept in the dark at 4 °C until analysis. Fluorescence intensity was assayed in the CyFLOW SPACE system 
(Partec, Munich, Germany). Cells in histogram with position characteristic for granular cells or lymphocytes and monocytes 
(mononuclear cells) were analyzed for percentages of CD11b
+
 cells. A minimum of 10,000 events/sample was acquired each time and 
analyzed using FlowMax software (Partec). 
 
2.13. Enzyme–linked immunosorbent assay (ELISA) 
Cytokine concentrations were determined in medium conditioned by spleen or lung cells using commercially available ELISA sets for 
rat IFN-γ (R&D Systems, Minneapolis, USA) and mouse IL–17 cross-reactive with rat IL-17 (eBioscience Inc., San Diego, CA, USA) 
according to the manufacturer's instructions. Cytokine titer was calculated by a reference to a standard curve constructed using known 
amounts of recombinant IFN-γ and IL-17. 
  
2.14. Reverse transcription and real time polymerase chain reaction (RT-PCR)  
Total RNA (1 μg) isolated from (5 × 106) total and mononuclear lung and spleen cells with mi-Total RNA Isolation Kit (Metabion, 
Martinsried, Germany) following manufacturer‟s instructions, was reverse transcribed using random hexamer primers and MMLV 
(Moloney Murine Leukemia Virus) reverse transcriptase according to the manufacturer's instructions (Fermentas, Vilnius, Lithuania). 
Prepared cDNAs were amplified using Power SYBR
®
 Green PCR Master Mix (Applied Biosystems, Foster City, California, USA) 
based on the recommendations of the manufacturer in a total volume of 20 μl in an ABI PRISM 7000 Sequence Detection System 
(Applied Biosystems). Thermocycler conditions comprised an initial step at 50 °C for 5 min, followed by a step at 95°C for 10 min 
and subsequent 2-step PCR program at 95 °C for 15 s and 60 °C for 60 s for 40 cycles. PCR primers (forward/reverse) used were: 
IFN-γ: 5'-AACAGTAAAGCAAAAAAGGATGCA-3'/5'-TGTGCTGGATCTGTGGGTTGT-3'; IL-17: 5'-
CTACCTCAACCGTTCCACTTCAC-3'/5'-CCTCCCAGATCACAGAAGGATATC-3'; MT – 1: 5'-
GAACTGCAAATGCACCTCCTGC-3'/5'-CAAGACTCTGAGTTGGTCCG-3'; MT – 2: 5'-TGCAAGAAAAGCTGCTGTTCC-3'/5'-
TTACACCATTGTGAGGACGCC-3'; inducible nitric oxide synthase (iNOS): 5'-TTCCCATCGCTCCGCTG-3'/5'-
CCGGAGCTGTAGCACTGCA-3'; β-actin (housekeeping): 5'-CCCTGGCTCCTAGCACCAT-3'/5'-
GAGCCACCAATCCACACAGA-3'. Accumulation of mRNA was detected in real time and results were analyzed with 7500 System 
Software (Applied Biosystems) and calculated as 2
−dCt
, where dCt was difference between threshold cycle (Ct) values of specific gene 
and endogenous control (β-actin). Data for mRNA from cells of cadmium administered animals are expressed as relative value to 
mRNA from control animals (considered as 1).  
 
2.15. Data display and statistical analysis 
Results were expressed as mean values (pooled from two independent experiments)  ± SD. The correlations were analyzed using 
Pearson correlation test. Statistical analysis was performed using STATISTICA 7.0 (StatSoft Inc., Tulsa, OK) and statistical 
significance was defined by a Mann-Whitney U test. A P-value < 0.05 was considered significant. 
 
3. Results 
3.1. General considerations   
Administration of cadmium resulted in accumulation of this metal in the liver, kidneys, spleen and lungs of both AO and DA rats with 
higher (compared to 0.5 mg of cadmium/ kg) concentrations in rats administered with the dose of 1 mg/kg (Fig. 1). Similar levels of 
this metal were noted in tissues of both strains, except in spleens of AO rats administered with 1 mg of cadmium/kg, where slightly, 
though significantly (P < 0.05), lower concentrations were noted in cadmium-treated AO (16.9 ± 3.3 µmol/kg) compared to DA rats 
(23.8 ± 3.9 µmol/kg). Somewhat higher (P < 0.05) concentrations of cadmium were measured in  lungs of AO rats administered with 
1 mg of cadmium/kg (6.1 ± 1.0 µmol/kg) compared to DA rats (4.5 ± 0.8 µmol/kg) (Fig. 1).  
No changes were noted in plasma levels of aspartate aminotransferase (AST) or alanine aminotransferase (ALT) at lower cadmium 
dose. At 1 mg/kg, increased plasma levels of both hepatic enzymes were noted in animals of both strains (275.1 ± 110.7 U/l compared 
to controls 157.1 ± 63.3 U/l, P < 0.05 in AO and 376.7 ± 110.8 U/l compared to controls 204.4 ± 45.5 U/l, P < 0.001 in DA rats for 
AST, and 100.8 ± 36.6 U/l vs. 50.7 ± 11.1 U/l in controls, P < 0.05 in AO and 151.8 ± 37.9 U/l vs. 76.1 ± 22.6 U/l in controls, P < 
0.001 in DA rats for ALT), but values were lower (P < 0.05) in AO compared to DA rats. No changes in urinary biochemical 
parameters in either of strains were observed at either of cadmium doses (data not shown). 
 
 
 
3.2. Histology    
Histological examination of livers of rats treated with 1 mg of cadmium/kg, showed presence of neutrophil infiltration in DA rats, 
while leukocyte presence was less obvious in AO rats (Fig. 2A, B). Histological examination of spleens (Fig. 2C, D) revealed 
neutrophil accumulation in red pulp of spleens of both strains. Analysis of spleen smears of cadmium-treated animals showed 
increases (compared to respective controls) not only in granulocytes (16.7 ± 2.5 % compared to 12.5 ± 0.7 % in AO rats, P < 0.05 and 
18.2 ± 4.4 % compared to 10.9 ± 4.1 % in DA rats, P < 0.01), but in numbers of metamyelocytes as well (4.7 ± 0.8 % vs. 2.4 ± 0.3 % 
in AO rats, P < 0.05 and 5.5 ± 1.9 % vs. 3.7 ± 1.5 % in DA rats, P < 0.05) with similar values in both strains. Histological examination 
of lungs (Fig. 2E, F) showed interstitial widening with leukocyte, predominantly neutrophil, infiltration. Neutrophils appear in focuses 
mainly perivascularly in AO rats and in the interstitium of DA rats. Histological evaluation of kidneys showed no differences between 
treated and control animals of both strains (data not shown). 
 
3.3. Spleen cell responses of AO and DA rats following cadmium administration  
Administration of 1 mg of cadmium/kg resulted in increase in relative spleen weight in cadmium-treated compared to control rats of 
both strains and in cellularity in AO rats (Table 1). No changes were observed in spleen cell viability of either of strains. 
Measurements of metallothionein (MT) spleen cell response revealed significantly higher levels of mRNA for both MT isoforms in 
spleen cells of cadmium-treated  rats of both strains (however lower levels of mRNA for MT-2 in AO compared to DA rats at higher 
cadmium dose were noted). 
Examination of spleen proliferative characteristics (Fig. 3) revealed no changes in spontaneous activity in either of strains. Stimulation 
with ConA resulted in increase in response both in controls and in cadmium-treated rats of both rat strains, but proliferation was lower 
(compared to controls) in groups of rats of both strains which received 1 mg of cadmium/kg (Fig. 3A). The degree of reduction of 
proliferative response, , however, was lower (P < 0.01) in AO rats (by 55.4 ± 2.7%) compared to 78.1 ± 5.4% in DA rats. When 
expression of CD25 (activation-inducible chain of IL-2 receptor), as well as proliferation in response to IL-2 in spleen cells of rats 
treated with higher cadmium dose were measured (Fig. 3B), a decrease in percentages of splenocytes that express these molecules was 
noted in cadmium-treated rats of both strains, but IL-2 stimulated proliferation was not affected in AO in contrast to DA rats (Fig. 3B). 
Measurements of spleen cell production of NO, which might inhibit cell proliferation, in medium conditioned by ConA-stimulated 
spleen cells (Fig. 3C) revealed increase in cultures of cells from cadmium-treated DA rats solely. Examination of iNOS mRNA 
showed lack of changes in AO rats in contrast to significantly higher levels in cadmium-treated vs. control DA rats. Examination of 
another aspect of oxidative activity of spleen cells, MPO activity, showed increase in cells of cadmium-administered animals of both 
strains (1.2 ± 0.4 compared to cells of the controls 0.6 ± 0.2, P < 0.05 in AO and 1.6 ± 0.6  compared to controls 0.4 ± 0.1, P < 0.01 in 
DA rats) with no strain differences.   
 Examination of IFN-γ spleen cell responses (Fig. 4A) revealed no changes in spontaneous activity in either of strains at either of 
cadmium doses. Similar levels (compared to those in controls) of ConA-stimulated IFN-γ production were noted at cadmium dose of 
0.5 mg/kg compared to controls. Lower (compared to controls) levels of IFN-γ production were noted at higher cadmium dose in both 
strains, but decrease was less pronounced in AO compared to DA rats (Fig. 4A). Decrease of IFN-γ mRNA was noted at this cadmium 
dose in cells of both strains (Fig. 4B). No effects of cadmium administration were seen on IL-17 responses (either at the level of 
protein product or at mRNA level), though a tendency (P = 0.06) of an increase of IL-17 mRNA was seen in spleen cells of DA rats at 
higher cadmium dose (Fig. 4C, D).  
Because cadmium administration results in accumulation of granulocytes (which might modulate or contribute to cytokine responses), 
mononuclear cell cytokine responses were measured next. Similar pattern of mononuclear cell IFN-γ (Fig. 4E, F) and IL-17 (Fig. 4G, 
H) response was observed, compared to total spleen cells, except in DA rats, where lower levels of ConA-stimulated production of IL-
17 were observed.   
 
3.4. Lung leukocyte responses of AO and DA rats following cadmium administration  
No changes in relative weight of lungs of both cadmium-treated AO and DA rats were noted (Table 2). While no differences were 
noted in numbers of leukocytes recovered from lungs of AO rats at either of cadmium doses, increased numbers of leukocytes were 
recovered from lungs of DA rats administered with 1 mg of cadmium/kg. No changes were observed in lung leukocyte viability. 
Measurements of MT response at lower cadmium dose revealed similar values of MT-1 mRNA, and a tendency of lower values of 
MT-2 mRNA (P = 0.06 in AO and P = 0.052 in DA rats) compared to controls. Significant increase of mRNA of both MT isoforms in 
lung cells of rats of both strains administered with 1 mg of cadmium/kg was detected, but higher values were noted in AO rats. 
Analysis of cytospin preparations of lung leukocytes from cadmium-treated rats revealed increased numbers of neutrophils only from 
lungs of rats treated with higher cadmium dose, but values were much lower in AO compared to DA rats. Drop in percentages of 
lymphocytes was seen at this dose in DA rats solely, while monocyte/macrophage numbers were lower in both stains. Measurements 
of MPO activity in homogenates of lung tissue from rats treated with 1mg of cadmium/kg confirmed neutrophil infiltration judging by 
increased (P < 0.01 vs. controls) values in cadmium-treated rats of both strains but values in AO (3.3 ± 0.3 U/g of tissue) were lower 
(P < 0.01) compared to 7.6 ± 0.9 U/g in DA rats. In addition, higher MPO activity was noted in leukocytes recovered from lungs of 
cadmium-treated rats of AO (1.6 ± 0.5 compared to cells of the controls 0.9 ± 0.4, P < 0.05) and DA strain (4.4 ± 0.9 compared to 
controls 0.7 ± 0.2, P < 0.05), but the levels were lower (P < 0.05) in the former strain.  
Because of the constant exchange of peripheral blood and lung leukocytes (mainly neutrophils), changes in differential peripheral 
blood leukocyte numbers were examined in rats treated with higher cadmium dose (Fig. 5). Increased numbers of total and 
neutrophilic leukocytes were noted in blood of cadmium-treated animals of both AO (Fig. 5A, B) and DA (Fig. 5D, E) strains, but the 
increase was less pronounced in AO rats. High (r = 0.94) and significant (P < 0.001) correlation was observed between peripheral 
blood and lung neutrophils of DA rats (Y = 5.35 + 0.68 × X) treated with cadmium. Lower level of correlation (r = 0.78) between 
neutrophillic leukocytes in these two compartments was seen in AO rats, but it was still significant (P < 0.01, Y = 18.96 + 1.11× X). 
Measurements of CD11b showed increased numbers of CD11b
+
 cells within granular cell population from blood, but the numbers 
were higher in DA (Fig. 5F) rats compared to AO (Fig. 5C).  
Examination of IFN-γ responses by lung cells showed similar levels of spontaneous IFN-γ production at cadmium dose of 0.5 mg/kg 
compared to controls, while lower levels were noted at higher cadmium dose in both strains (Fig. 6A). Similar pattern of changes of 
this cytokine was noted following stimulation with ConA and the effect was seen at lower Cd dose in DA rats, solely. To see if 
decreased production at 1 mg of cadmium/kg was noted because of lower percentages of lymphocytes, IFN-γ production by 
mononuclear cells was measured next (Fig. 6B), and results showed decreased spontaneous and ConA-stimulated production in treated 
animals of both strains. Decreases of IFN-γ mRNA were noted in both total (Fig. 6C) and mononuclear (Fig. 6D) lung cells in both 
strains.   
No effect was seen on IL-17 production by total lung leukocytes of AO rats at either of cadmium doses, while a decrease was seen at 1 
mg of cadmium/kg in DA rats (Fig. 6E). The effect   on lung mononuclear leukocytes at higher metal dose was seen as well (Fig. 6F). 
In addition, level of IL-17 mRNA was decreased in total and mononuclear lung cells of DA rats (Fig. 6G, H).  
 
4. Discussion 
In the present study, toxicity of acute cadmium administration was examined by analyzing changes in  spleen (most often explored in 
the context of cadmium immunotoxicity) and lungs (known target for cadmium) in two rat strains with disparate susceptibility to 
environmental stimuli. Slight differences of cadmium concentrations in the tissue might have accounted for higher levels of MT 
response in  spleen of DA rats and in lungs of AO rats, but genetic factors seemed most important contributors to differences between 
these strains  in the toxicity of this metal to these immune compartments The presence or absence of some of the effects or their 
intensity , however, depended on the tissue and the specific cell activity  examined.  
Increases in spleen cellularity in AO rats might have resulted from cell migration to spleens and/or less pronounced suppression of cell 
proliferation. Lack of increase in spleen cellularity in DA rats might be ascribed to lower responsiveness to IL-2 (major lymphocyte 
growth factor) and to increased production of nitric oxide (known to inhibit lymphocyte proliferation). The effects of somewhat higher 
cadmium levels in spleen of DA rats might have contributed to more pronounced decrease in spleen cell proliferation of this strain as 
well, although greater differences (near or more than 50%) in cadmium tissue deposition were reported as responsible for strain 
differences in cadmium hepatotoxicity and testicular toxicity (Shimada et al., 2004, 2009). Lower percentages of CD25 (inducible 
chain of IL-2 receptor) positive spleen cells noted in both strains exposed to cadmium along with a decrease in IL-2-driven 
proliferation in DA rats solely, implies strain differences in pathways involved in IL-2/IL-2R signaling. Indeed, differences between 
AO and DA rats in IL-2 responses were noted previously (Vukmanović et al., 1989). Production of NO by spleen cells from cadmium-
treated DA rats might have deepened lower responsiveness of splenocytes from this strain to IL-2, as interference of NO with IL-2/IL-
2R signaling pathways was reported (Bingisser et al., 1998; Mazzoni et al., 2002). Differential levels in produced NO between strains 
rely on iNOS transcription, in line with data that showed differences between murine strains in NO production and iNOS gene 
transcription in other experimental systems (Evans et al., 1993; Zidek et al., 2000).  
Lower level of inhibition of IFN-γ production by both total and mononuclear spleen cells of AO rats in response to stimulation with 
ConA (though similar level of decrease in the cytokine mRNA were observed in both strains) show that differential responsiveness to 
stimuli is responsible for disparate cytokine production between strains. Lack of the general effect of cadmium administration on 
spleen cell production and expression of IL-17, show, that at least for leukocytes of this compartment, IL-17 is not directly affected. A 
decrease of responsiveness of IL-17 production by spleen mononuclear cells of DA rats show, however, that cadmium administration 
might affect this cytokine in  spleen.  
 
Neutrophil infiltration into the lungs of both strains depicts proinflammatory activity of cadmium in this tissue, but with marked strain 
differences. Lower numbers of neutrophil leukocytes recovered from lungs of AO rats might have resulted from lower degree of 
increases in peripheral blood neutrophils in these rats. Lungs harbor intravascular reservoirs of leukocytes, predominantly neutrophils 
(termed „marginated pool‟) that constantly exchange with circulating neutrophils (Kuebler, 2005). High and significant correlation 
between numbers of neutrophils in the peripheral blood and those recovered from lungs, corroborate such considerations. Lower 
number of neutrophils in lungs of AO rats might have resulted from lower percentages of CD11b
+
 cells in the peripheral blood of 
these rats, as these molecules are involved in neutrophil extravasation and migration to peripheral tissue (Arnaout, 1990). Inhibition of 
IFN-γ, at both transcription as well as protein product levels in mononuclear cells of both spleen and lungs, implies that this cytokine 
is an absolute target for cadmium, in line with numerous data from human peripheral blood mononuclear cells (Boscolo et al., 2005; 
Hemdan et al., 2006; Marth et al., 2001; Pathak and Khandelwal, 2008; Shen et al., 2001). Lack of differences between AO and DA 
rats in the degree of decrease of ConA-stimulated production of IFN-γ by lung leukocytes (in contrast to spleen cells where they were 
observed), showed that strain-related differences in the particular activity depend on the immune compartment in which it is 
examined. Differences in IL-17 gene transcription and protein product expression by lung leukocytes (together with effects on ConA-
stimulated production of  cytokine by spleen cells) , for the first time, showed strain differences in the effect of cadmium on IL-17 
response.  
 
5. Conclusion 
Strain differences in the effects of acute cadmium administration were shown in two compartments of immune system: spleen and 
lungs. Although contribution of slight differences of cadmium concentrations in the tissue could not be ruled out, genetically based 
differences seemed more important contributing factors. The impact of strain, however, differs between these compartments and in 
relation to the activity  examined. On the basis of less intense suppression or lack of the effect on some aspects of spleen and lung cell 
activity, AO rats seemed less susceptible to cadmium. This suggests that attention should be paid on selection of animal strain in 
studies of cadmium immunotoxicity. 
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Figure captions: 
Fig. 1. Cadmium tissue content. Results are expressed as mean ± S.D. from two experiments with four to six animals per group per 
experiment. Significance at: ** P < 0.01 vs. control (cadmium 0 mg/kg), ^^ P < 0.01 for higher vs. lower dose, and # P < 0.05, ## P < 
0.01 for AO vs. DA rats. 
 
Fig. 2. Histology of liver, spleen and lungs of AO and DA rats administred with cadmium. Leukocyte infiltration in liver of (A) 
AO rats and (B) DA rats (× 200). Neutrophillic leukocytes in the red pulp of spleens of (C) AO and (D) DA rats (× 400). (E) Focuses 
of neutrophils perivascularly in the lungs of AO rats (× 200). (F) Neutrophils in the interstitium of the lungs of DA rats (× 200).  
 
Fig. 3. The effect of cadmium on proliferative characteristics of spleen cells in AO and DA rats. (A) Spontaneous and ConA-
stimulated proliferation. (B) Number of CD25
+
 cells and IL-2- stimulated proliferation. (C) Nitric oxide (NO) level in spleen cells 
conditioned medium, and iNOS mRNA levels. Results are expressed as mean ± S.D. Significance at: * P < 0.05, ** P < 0.01, *** P < 
0.001 vs. control (cadmium 0 mg/kg), and # P < 0.05 for AO vs. DA. 
 
Fig. 4. The effect of cadmium on spleen cell IFN-γ and IL-17 protein product and mRNA levels in AO and DA rats. Total 
spleen cells IFN-γ (A) and IL-17 (C) production, and mRNA expression (B and D, respectively). Mononuclear spleen cells IFN-γ (E) 
and IL-17 (G) production, and mRNA expression (F and H, respectively). Results are expressed as mean ± S.D. Significance at: * P < 
0.05, ** P < 0.01, *** P < 0.001 vs. control (cadmium 0 mg/kg), and # P < 0.05, ### P < 0.001 for AO vs. DA rats. 
 
Fig. 5. The effect of cadmium on peripheral blood leukocyte number and expression of CD11b molecule in AO and DA rats. 
Total leukocyte number, differential cell count and number of CD11b
+
 cells in peripheral blood of AO (A, B, C respectively) and DA 
rats (D, E, F respectively). Results are expressed as mean ± S.D. Significance at: * P < 0.05, ** P < 0.01, *** P < 0.001 vs. control 
(cadmium 0 mg/kg), and # P < 0.05, ## P < 0.01 for AO vs. DA rats. 
 
Fig. 6. The effect of cadmium on lungs cell IFN-γ and IL-17 protein product and mRNA levels in AO and DA rats. Total and 
mononuclear lungs cells IFN-γ production (A and B, respectively) and mRNA expression (C and D, respectively). Total and 
mononuclear lungs cell IL-17 production (E and F, respectively) and mRNA expression (G and H, respectively).  Results are 
expressed as mean ± S.D. Significance at: * P < 0.05, ** P < 0.01, *** P < 0.001 vs. control (cadmium 0 mg/kg).  
 
 
 
 
 Table 1. 
The effect of cadmium administartion on spleen weight, cellularity, cell viability and metallothionein (MT) response 
 AO  DA 
 Cadmium dose (mg/kg)  Cadmium dose (mg/kg) 
Parameters           0          0.5           1            0         0.5           1 
Relative weight  
(mg/g body weight) 
  1.70 ± 0.32   2.23 ± 0.55   2.46 ± 0.99*** 
 
  1.68 ± 0.16   1.74 ± 0.13   2.02 ± 0.25*** 
Cellularity  
(× 106/per spleen) 
299.3 ± 99.0 290.2 ± 83.5 440.1 ± 130.3*** 
 
271.5 ± 49.7 205.9 ± 98.8 288.8 ± 73.5 
Cell viability  
(A 540nm) 
  0.29 ± 0.05   0.26 ± 0.08   0.28 ± 0.00 
 
  0.23 ± 0.02   0.27 ± 0.06   0.24 ± 0.09 
MT – 1 mRNA expression 
(relative values) 
  1.00 ± 0.49   2.48 ± 1.48**   2.26 ± 1.77* 
 
  1.00 ± 0.20   2.46 ± 0.75*   2.36 ± 1.00** 
MT – 2 mRNA expression   1.01 ± 0.51   2.92 ± 1.33**   3.93 ± 2.30**## 
 
  1.03 ± 0.19   3.72 ± 2.97** 12.00 ± 2.19**^^ 
(relative values) 
Results are expressed as mean ± S.D. from two experiments with four to six animals per group per experiment. Significance at: * P < 0.05; ** 
P < 0.01; *** P < 0.001 vs. control (cadmium 0 mg/kg), ^^ P < 0.01 for higher (1mg/kg) vs. lower dose (0.5 mg/kg), and ## P < 0.01 for AO vs. 
DA. 
 
 
 Table 2. 
The effect of cadmium administration on lung weight, leukocyte recovery, cell viability, metallothionein (MT) response and differential 
leukocyte count. 
 AO  DA 
 Cadmium dose (mg/kg)  Cadmium dose (mg/kg) 
Parameters         0          0.5         1          0        0.5         1 
Relative weight  
(mg/g body weight) 
6.10 ± 1.87 6.62 ± 1.07 5.90 ± 1.12 
 
6.30 ± 1.60 5.80 ± 0.45 6.63 ± 1.71 
Leukocyte recovery  
(× 106/ per lung) 
16.2 ± 8.9 18.4 ± 5.3 20.0 ± 9.2 
 
16.7 ± 5.0 15.9 ± 2.7 29.1 ± 5.2*** 
Cell viability  
(A 540nm) 
0.62 ± 0.09 0.49 ± 0.16 0.55 ± 0.10 
 
0.55 ± 0.13 0.43 ± 0.15 0.43 ± 0.14 
MT – 1 mRNA expression 
 (relative values) 
1.00 ± 0.62 0.96 ± 0.06 4.58 ± 2.41**## 
 
1.00 ± 0.26 1.34 ± 1.25 1.69 ± 0.25** 
  
MT – 2 mRNA expression  
(relative values) 
1.00 ± 0.51 0.33 ± 0.43 4.89 ± 1.66**# 
 
1.00 ± 1.00 0.32 ± 0.48 2.29 ± 0.62* 
Differential leukocyte count (%) 
       
Neutrophils   6.9 ± 3.5   8.8 ± 2.4 32.4 ± 7.9**## 
 
11.1 ± 7.6 10.8 ± 6.1 60.1 ± 8.4*** 
Lymphocytes 55.9 ± 12.3 51.1 ± 18.5 48.9 ± 10.6 
 
63.1 ± 8.7 61.0 ± 18.5 25.9 ± 8.1** 
Monocytes/Macrophages 37.1 ± 13.7 40.1 ± 7.3 18.6 ± 7.4* 
 
25.8 ± 10.6 28.0 ± 3.7 14.0 ± 5.7* 
Results are expressed as mean ± S.D. from two experiments with four to six animals per group per experiment. Significance at: * P < 0.05; 
** P < 0.01; *** P < 0.001 vs. control (cadmium 0 mg/kg), and # P < 0.05, ## P < 0.01 for AO vs. DA. 
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